Search results
Michael Mosley – latest: TV doctor’s body to be repatriated as BBC says it will air last interview
The Independent via Yahoo News· 1 hour agoDr Mosley based his book The 8-Week Blood Sugar Diet on research by Roy Taylor, who is a professor...
Lilly’s Weight-Loss Drug Is a Huge Hit. Its CEO Wants to Replace It ASAP.
The Wall Street Journal· 5 hours agoThis was a race he couldn’t lose. Rival Novo Nordisk was already ahead. Its diabetes drug Ozempic...
Social Media Believes This is the Real Reason Behind Oprah Winfrey's Hospitalization
The Root· 1 day agoThrough X and Tik Tok, critics are claiming the cause of Winfrey’s hospitalization is her use of...
Study finds diabetes increases the risk of failure in spinal fusion procedures
Medical Xpress· 12 hours agoThe results of the study were published in the journal JBMR Plus and were recently presented at the...
Study hints at tools to prevent diabetes associated with antipsychotic medications
Medical Xpress· 16 hours agoNew University of Pittsburgh research points to a potential approach to reducing the risk of ...
Ozempic, Wegovy, Mounjaro popularity soar as weight loss wonders
Pittsburgh Tribune-Review· 20 hours agoFor Diane Lang, the big push to focus on her health and weight came from her grandchildren. Lang, of...
Mama June Shannon Reveals She Lost 30 Pounds Using Weight Loss Medication - E! Online
E! Online· 13 hours agoMama June Shannon is sharing insight into her weight loss journey. The Mama June: Family Crisis star...
Continuous Glucose Monitors Should Not Be Normalized
Medscape· 2 days agoShould we now recommend continuous glucose monitoring to all our patients, even those without diabetes? Most of us would instinctively say "no" to this...
N.S. program to help pay for diabetes care leaves out many who rely on insulin
CBC via Yahoo News· 3 days agoA Nova Scotia program that helps cover the cost of sensor-based glucose monitors for people with ...
AstraZeneca's Farxiga Approved For Treating Pediatric Type-2 Diabetes in U.S.
Morningstar· 1 day agoAstraZeneca's diabetes drug Farxiga on Wednesday was approved by U.S. regulators for the treatment of type-2 diabetes in children 10 and older. Farxiga, ...